ArticleVeterinary sciences2025
Self-Adhesive, Human Bandage Contact Lens Versus Conjunctival Transposition Flap for Surgical Repair of Feline Corneal Sequestrum.
Article in Veterinary sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Corneal sequestrum, also known as corneal mummification or necrosis, is a common complication of corneal ulceration in cats, with brachycephalic and pure-bred cats being the most affected. This prospective clinical trial aimed to evaluate the efficacy of self-adhesive, human bandage contact lenses (SHBCLs) versus the commonly used conjunctival transposition flap (CTF) in the management of feline corneal sequestrum. Twenty-five client-owned cats of different breeds with unilateral corneal sequestrum were investigated. All cats underwent a complete ophthalmic examination. Characterization of corneal sequestrum was carried out. The corneal lesion was removed surgically via keratectomy, and the cats were then categorized into three treatment groups: G-SHBCL (10 cats), G-CTF (10 cats), and the control group (G-CO, 5 cats). The healing progress of the corneal defect and associated clinical findings were recorded in all studied groups. Eight out of ten cats (80%) treated with SBCLs showed complete healing of the corneal defect with light corneal scarring and absence of all signs of ocular pain or discomfort. In comparison with G-CTF and G-CO, no granulation tissue was observed in all cats treated with SHBCLs. Moreover, no residues of corneal sequestrum or adhesion were identified, and the degree of corneal clarity was higher in the SHBCL treatment group. In conclusion, application of SHBCLs on a corneal defect, after removal of the associated sequestrum, enhances healing of the cornea and markedly improves the corneal clarity and transparency within a short period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.